Furthermore, high expression of NADK in NSCLC patients predicted a poor survival (Figure 1A), which was consistent with the data described in the Kaplan‒Meier plotter database (Figure 1B-C) and GEPIA database (Supplementary Figure 1E). Here, NADK is linked to non-small cell lung carcinoma.